Showing posts with label Guidance Lay Out FDA Enforcement Plan For Drug Supply Chain. Show all posts
Showing posts with label Guidance Lay Out FDA Enforcement Plan For Drug Supply Chain. Show all posts

Monday, July 15, 2013

Proposed Rule, Guidance Lay Out FDA Enforcement Plan For Drug Supply Chain


FDA is taking steps to institute a drug supply chain enforcement plan under which the agency would detain drugs it believes are adulterated as well as penalize manufacturers that do not comply with agency inspectors, issuing a proposed rule and draft guidance Friday (July 12) mandated by the FDA Safety and Innovation Act.
more information at InsideHealthPolicy

Friday, July 12, 2013

Proposed Rule, Guidance Lay Out FDA Enforcement Plan For Drug Supply Chain


FDA is taking steps to institute a drug supply chain enforcement plan under which the agency would detain drugs it believes are adulterated as well as penalize manufacturers that do not comply with agency inspectors, issuing a proposed rule and draft guidance Friday (July 12) mandated by the FDA Safety and Innovation Act.


quoted from here